Schonfeld Strategic Advisors’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-74,982	Closed	-$6.28K	–	2691
2023 Q1	$6.28K	Hold	74,982	–	–	﹤0.01%	1885
2022 Q4	$382	Buy	74,982 +29,982	+67%	+$1.48K	﹤0.01%	2512
2022 Q3	$6K	Buy	45,000 +20,000	+80%	+$3.51K	﹤0.01%	2747
2022 Q2	$3K	Buy	+25,000	New	+$5.1K	﹤0.01%	2377

Schonfeld Strategic Advisors's LVACW Position: Q2 2023 in Review

Schonfeld Strategic Advisors sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 74,982 shares — an estimated $6.28K sold.

Schonfeld Strategic Advisors first reported a position in LVACW in Q2 2022 and held it in 4 quarters. The position peaked at $6.28K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Schonfeld Strategic Advisors reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 74,982 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $6.28K.
Schonfeld Strategic Advisors first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q2 2022 and held it in 4 quarters.
Schonfeld Strategic Advisors's LAVA Medtech Acquisition Corp. Warrants position peaked at $6.28K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.